返回 Agenda
Session 3: A Year in Review: FDA Updates
Session Chair(s)
Tamei Elliott, MS
Director, Global Scientific Content
DIA, United States
Over the past year, the U.S. Food and Drug Administration (FDA) has continued its modernization efforts, implementing significant changes in regulatory processes and technological advancements to enhance efficiency, transparency, and compliance in regulatory submissions. This session will provide a comprehensive review of key FDA updates and notable FDA guidance documents issued over the past year. Additionally, emerging trends, regulatory shifts, and insights that have shaped the FDA’s approach to regulatory submissions and information management will be discussed.
Learning Objective : - Describe the latest advancements, key developments and major changes within the FDA as it relates to regulatory submissions and information management
Speaker(s)
Speakers
Tamei Elliott, MS
DIA, United States
Director, Global Scientific Content